Reformable intramolecular cross-linking of the N-terminal domain of heparin cofactor II - Effects on enzyme inhibition

被引:11
作者
Brinkmeyer, S [1 ]
Eckert, R [1 ]
Ragg, H [1 ]
机构
[1] Univ Bielefeld, Fac Technol, Dept Biotechnol, D-33501 Bielefeld, Germany
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 21期
关键词
alpha-thrombin; dermatan sulfate; heparin cofactor II; heparin; serpin(s);
D O I
10.1111/j.1432-1033.2004.04367.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of a heparin cofactor II (HCII)-thrombin Michaelis complex has revealed extensive contacts encompassing the N-terminal domain of HCII and exosite I of the proteinase. In contrast, the location of the N-terminal extension in the uncomplexed inhibitor was unclear. Using a disulfide cross-linking strategy, we demonstrate that at least three different sites (positions 52, 54 and 68) within the N terminus may be tethered in a reformable manner to position 195 in the loop region between helix D and strand s2A of the HCII molecule, suggesting that the N-terminal domain may interact with the inhibitor scaffold in a permissive manner. Cross-linking of the N terminus to the HCII body does not strongly affect the inhibition of alpha-chymotrypsin, indicating that the reactive site loop sequences of the engineered inhibitor variants, required for interaction with one of the HCII target enzymes, are normally accessible. In contrast, intramolecular tethering of the N-terminal extension results in a drastic decrease of alpha-thrombin inhibitory activity, both in the presence and in the absence of glycosaminoglycans. Treatment with dithiothreitol and iodoacetamide restores activity towards alpha-thrombin, suggesting that release of the N terminus of HCII is an important component of the multistep interaction between the inhibitor and alpha-thrombin.
引用
收藏
页码:4275 / 4283
页数:9
相关论文
共 42 条
[1]   Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism [J].
Baglin, TP ;
Carrell, RW ;
Church, FC ;
Esmon, CT ;
Huntington, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11079-11084
[2]   HEPARIN-COFACTOR .2. CDNA SEQUENCE, CHROMOSOME LOCALIZATION, RESTRICTION FRAGMENT LENGTH POLYMORPHISM, AND EXPRESSION IN ESCHERICHIA-COLI [J].
BLINDER, MA ;
MARASA, JC ;
REYNOLDS, CH ;
DEAVEN, LL ;
TOLLEFSEN, DM .
BIOCHEMISTRY, 1988, 27 (02) :752-759
[3]   Tyrosine sulfation and N-glycosylation of human heparin cofactor II from plasma and recombinant Chinese hamster ovary cells and their effects on heparin binding [J].
Böhme, C ;
Nimtz, M ;
Grabenhorst, E ;
Conradt, HS ;
Strathmann, A ;
Ragg, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (03) :977-988
[4]   STRUCTURE-FUNCTION RELATIONSHIPS IN HEPARIN COFACTOR-II - SPECTRAL-ANALYSIS OF AROMATIC RESIDUES AND ABSENCE OF A ROLE FOR SULFHYDRYL-GROUPS IN THROMBIN INHIBITION [J].
CHURCH, FC ;
MEADE, JB ;
PRATT, CW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1987, 259 (02) :331-340
[5]   INHIBITION OF CHYMOTRYPSIN BY HEPARIN COFACTOR-II [J].
CHURCH, FC ;
NOYES, CM ;
GRIFFITH, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (19) :6431-6434
[6]   Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II [J].
Ciaccia, AV ;
Willemze, AJ ;
Church, FC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :888-893
[7]   Probing protein folding and stability using disulfide bonds [J].
Darby, N ;
Creighton, TE .
MOLECULAR BIOTECHNOLOGY, 1997, 7 (01) :57-77
[8]   Immobilization of the distal hinge in the labile serpin plasminogen activator inhibitor 1 - Identification of a transition state with distinct conformational and functional properties [J].
De Taeye, B ;
Compernolle, G ;
Dewilde, M ;
Biesemans, W ;
Declerck, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23899-23905
[9]   Zinc ions promote the interaction between heparin and heparin cofactor II [J].
Eckert, R ;
Ragg, H .
FEBS LETTERS, 2003, 541 (1-3) :121-125
[10]   Simultaneous introduction of multiple mutations using overlap extension PCR [J].
Ge, LM ;
Rudolph, P .
BIOTECHNIQUES, 1997, 22 (01) :28-&